Regeneron Disclaims an Aflibercept Formulation Patent in Response to Celltrion PGR

March 30, 2022

PTAB Institutes a Second IPR on Rituxan®-related ’821 Patent

August 1, 2018

Immunex Loses Battle Over Institution of Follow-on IPR Petitions

March 23, 2018

Supreme Court Oral Argument in Oil States

December 12, 2017

The Potential Impact of the Supreme Court’s Decision in Oil States

November 22, 2017

The Supreme Court’s Decision in Amgen v. Sandoz: Clear Guidance and Open Questions for Biosimilars

July 21, 2017